Aeras is excited to attend The 48th Union World Conference on Lung Health from October 11-14 in Guadalajara, Mexico.

Data analysis for the first-ever Prevention of Infection (POI) clinical trial of a new TB vaccine has begun.

Aeras participated in the WHO Initiative for Vaccine Research (IVR) and Global Tuberculosis Program Consultation on TB Vaccine R&D.